Drug Profile
Dizocilpine
Alternative Names: MK-801Latest Information Update: 24 Mar 2010
Price :
$50
*
At a glance
- Originator Merck & Co
- Developer Merck & Co; Nonindustrial source
- Class Analgesics; Antiepileptic drugs; Antiparkinsonians; Antivirals; Dibenzocycloheptenes; Neuroprotectants; Small molecules
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 24 Nov 1998 A study has been added to the Pain pharmacodynamics section
- 29 Oct 1998 A preclinical study has been added to the Neurological disorders pharmacodynamics section
- 03 Jun 1997 A study has been added to the Pain pharmacodynamics section